Efficacy of xanthine oxidase inhibitor for chronic kidney disease patients with hyperuricemia

ConclusionsIn this study, XO inhibitors did not significantly reduce the uPCR in chronic kidney disease stage 3 and 4 patients with hyperuricemia.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research